Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Salicylic acid 2% in Generic Unguentum M cream
1305020S0AACVCV
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 9 |
|
Salicylic acid 20% in Aqueous cream
1305020S0AABPBP
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 9 |
|
Sterets Tisept solution 100ml sachets
1311020L0BRAAAW
|
Sterets Tisept | Chlorhexidine gluconate | Skin | 9 |
|
Sucralfate powder
1313080S0AAADAD
|
Sucralfate (Topical) | Sucralfate | Skin | 9 |
|
Ultrasun Sports gel SPF 20
130801000BBPBA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 9 |
|
Chlorhexidine glucon 0.015%/Cetrimide 0.15% soln 100ml sach
1311020L0AAAWAW
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 8 |
|
Cuderm moisturising hand cream
130201000BBLYA0
|
Proprietary compound emollients | Other emollient preparations | Skin | 8 |
|
Eucerin Intensive 5% hand cream
1302010U0BGAHAK
|
Eucerin | Urea | Skin | 8 |
|
Gentamicin 0.1% cream
1310012I0AAAEAE
|
Gentamicin sulfate (Topical) | Gentamicin sulfate | Skin | 8 |
|
Germolene Wound Care cream
1310050W0BBAAAA
|
Germolene Wound Care | Chlorhex hydrochloride | Skin | 8 |
|
Neomycin 0.5% cream
1310011P0AAAAAA
|
Neomycin sulfate (Topical) | Neomycin sulfate | Skin | 8 |
|
Salicylic acid 2% in Emulsifying ointment
1305020S0AACHCH
|
Salicylic acid (Psoriasis) | Salicylic acid | Skin | 8 |
|
Scholl Athlete's Foot liquid spray
1310020Y0BEAFAP
|
Scholl (Athletes Foot) | Tolnaftate | Skin | 8 |
|
Triple Dry Anti-perspirant roll-on
131200000BBACA0
|
Proprietary compound preparation BNF 1312000 | Other antiperspirant preparations | Skin | 8 |
|
Ultrasun anti-ageing face cream SPF 50+
130801000BBPGA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 8 |
|
ChloraPrep with Tint solution 26ml applicators
1311020L0CHAHBZ
|
ChloraPrep | Chlorhexidine gluconate | Skin | 7 |
|
ChloraPrep with Tint solution 3ml applicators
1311020L0CHAFBV
|
ChloraPrep | Chlorhexidine gluconate | Skin | 7 |
|
Chlorhexidine glucon 2%/Isopropyl alcohol 70% soln 10.5ml
1311020L0AABYBY
|
Chlorhexidine gluconate (Topical cleanser) | Chlorhexidine gluconate | Skin | 7 |
|
Coal tar 20% in Yellow soft paraffin
1305020C0AAEKEK
|
Coal tar/tar (Topical) | Tars | Skin | 7 |
|
Coal tar solution strong 1% in Emulsifying ointment
1305020C0AAFQFQ
|
Coal tar/tar (Topical) | Tars | Skin | 7 |
|
Coal tar solution strong 5% in Emulsifying ointment
1305020C0AAFIFI
|
Coal tar/tar (Topical) | Tars | Skin | 7 |
|
Elena's Day Cream Special
130501000BBBAA0
|
Proprietary compound preparation BNF 1305010 | Other eczema preparations | Skin | 7 |
|
Paraffin hard solid
1301010P0AAAAAA
|
Paraffin Hard | Paraffin hard | Skin | 7 |
|
Riemann P20 lotion SPF 20
130801000BBNYA0
|
Proprietary compound preparation BNF 1308010 | Other sunscreening preparations | Skin | 7 |
|
Witch Doctor gel
1311060H0BCAAAB
|
Witch Doctor | Hamamelis | Skin | 7 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.